Core Laboratories annual shares outstanding
2022
2023
2024
2025
Core Laboratories Shares Outstanding History (CLB)
Core Laboratories reported 46.1M shares outstanding at the end of fiscal 2025.
View full Core Laboratories company overviewCore Laboratories annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 46.1M | −731,441 | −1.56% |
| 2024 | 2024-12-31 | 46.8M | −29,716 | −0.06% |
| 2023 | 2023-12-31 | 46.9M | 224,602 | +0.48% |
| 2022 | 2022-12-31 | 46.6M | — | — |
Core Laboratories quarterly shares outstanding
Q4.22
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 45.9M | −652,690 | −1.40% |
| Q1 2026 | 2026-03-31 | 46.0M | −653,924 | −1.40% |
| Q4 2025 | 2025-12-31 | 46.1M | −731,441 | −1.56% |
| Q3 2025 | 2025-09-30 | 46.1M | −840,447 | −1.79% |
| Q2 2025 | 2025-06-30 | 46.5M | −375,905 | −0.80% |
| Q1 2025 | 2025-03-31 | 46.7M | −162,174 | −0.35% |
| Q4 2024 | 2024-12-31 | 46.8M | −29,716 | −0.06% |
| Q3 2024 | 2024-09-30 | 46.9M | 228,826 | +0.49% |
| Q2 2024 | 2024-06-30 | 46.9M | 232,286 | +0.50% |
| Q1 2024 | 2024-03-31 | 46.9M | 232,432 | +0.50% |
| Q4 2023 | 2023-12-31 | 46.9M | — | — |
| Q3 2023 | 2023-09-30 | 46.7M | — | — |
| Q2 2023 | 2023-06-30 | 46.7M | — | — |
| Q4 2022 | 2022-12-31 | 46.6M | — | — |
Core Laboratories shares outstanding trends
Across the available reported history, Core Laboratories's shares outstanding moved from 46.8M to 46.1M, a change of −731,441. The latest reported quarter, Q2 2026, shows 45.9M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Laboratories filings at SEC.gov ↗